A cohort study on Helicobacter pylori infection associated with nonalcoholic fatty liver disease (Q40255786)

18 September 2017

A cohort study on Helicobacter pylori infection associated with nonalcoholic fatty liver disease (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

18 September 2017

1 reference

1 reference

Helicobacter pylori infectious disease

inferred from title

1 reference

Tae Jun Kim

1

1 reference

18 September 2017

Dong Hyun Sinn

2

1 reference

18 September 2017

Yang Won Min

3

1 reference

18 September 2017

Hee Jung Son

4

1 reference

18 September 2017

Jae J Kim

5

1 reference

18 September 2017

Yoosoo Chang

6

1 reference

18 September 2017

Sun-Young Baek

7

1 reference

18 September 2017

Soo Hyun Ahn

8

1 reference

18 September 2017

Hyuk Lee

9

1 reference

18 September 2017

Seungho Ryu

10

1 reference

18 September 2017

5 April 2017

1 reference

Journal of Gastroenterology

18 September 2017

1 reference

Recent developments in the epidemiology of Helicobacter pylori

18 September 2017

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1337-Y

The translation of Helicobacter pylori basic research to patient care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1337-Y

Helicobacter pyloriInfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1337-Y

Helicobacter pylori and extragastric diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1337-Y

Association between Helicobacter pylori Seropositivity and the Coronary Artery Calcium Score in a Screening Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1337-Y

The effect of helicobacter pylori eradication on liver fat content in subjects with non-alcoholic Fatty liver disease: a randomized open-label clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1337-Y

Helicobacter pylori infection associated with high HbA1c and type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1337-Y

Helicobacter Pylori infection is a significant risk for modified lipid profile in Japanese male subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1337-Y

Helicobacter pylori infection is significantly associated with metabolic syndrome in the Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1337-Y

KASL clinical practice guidelines: management of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1337-Y

NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1337-Y

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1337-Y

Nonalcoholic fatty liver disease and metabolic syndrome: Shared genetic basis of pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1337-Y

Potential role of Helicobacter pylori infection in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1337-Y

Helicobacter pylori infection might have a potential role in hepatocyte ballooning in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1337-Y

Helicobacter pylori infection is not associated with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1337-Y

Helicobacter pylori infection in patients with nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1337-Y

Helicobacter pylori infection is not associated with fatty liver disease including non-alcoholic fatty liver disease: a large-scale cross-sectional study in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1337-Y

Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1337-Y

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1337-Y

Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1·8 million participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1337-Y

Estimating the proportion of treatment effect explained by a surrogate marker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1337-Y

"Proportion explained": a causal interpretation for standard measures of indirect effect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1337-Y

Development, external validation, and comparative assessment of a new diagnostic score for hepatic steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1337-Y

The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1337-Y

Importance of childhood socioeconomic status on the current prevalence of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1337-Y

Relation of adult lifestyle and socioeconomic factors to the prevalence of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1337-Y

A cross-sectional study of socioeconomic status and the metabolic syndrome in Korean adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1337-Y

The association between Helicobacter pylori infection and insulin resistance: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1337-Y

Helicobacter pylori infection and fasting plasma glucose concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1337-Y

NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1337-Y

A lipidomic analysis of nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1337-Y

Helicobacter pylori is associated with dyslipidemia but not with other risk factors of cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1337-Y

Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1337-Y

In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1337-Y

Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1337-Y

Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1337-Y

Defining nonalcoholic fatty liver disease: implications for epidemiologic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1337-Y

Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1337-Y

Prevalence and risk factors of Helicobacter pylori infection in Korea: nationwide multicenter study over 13 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1337-Y

Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised edition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1337-Y

Diagnosis and treatment guidelines for Helicobacter pylori infection in Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1337-Y

Seroprevalence of Helicobacter pylori in South Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1337-Y

Helicobacter pylori infection, insulin resistance and nonalcoholic fatty liver disease

21 January 2018

1 reference

12 December 2020

[Relationship of socioeconomic status and non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus].

1 reference

12 December 2020

Infection with Helicobacter pylori, coronary heart disease, cardiovascular risk factors, and systemic inflammation: the Third National Health and Nutrition Examination Survey.

1 reference

12 December 2020

Validation of fatty liver index and lipid accumulation product for predicting fatty liver in Korean population

1 reference

12 December 2020

Ultrasound scanning in the detection of hepatic fibrosis and steatosis

1 reference

12 December 2020

NAFLD and cardiovascular risk: direct evidence for the tale of two ages

1 reference

12 December 2020

[Helicobacter pylori infection and liver diseases]

1 reference

12 December 2020

10.1007/S00535-017-1337-Y

Identifiers

DOI

1 reference

18 September 2017

1 reference